ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Negative, Chronic Hepatitis B: Week 48 Efficacy and Safety Results
Journal of Hepatology
◽
10.1016/s0168-8278(16)01637-8
◽
2016
◽
Vol 64
(2)
◽
pp. S135-S136
◽
Cited By ~ 7
Author(s):
M. Buti
◽
E. Gane
◽
W.K. Seto
◽
H.L.Y. Chan
◽
W.-L. Chuang
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
◽
Negative Chronic Hepatitis
Download Full-text
Related Documents
Cited By
References
Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Negative, Chronic Hepatitis B Patients: A Global Phase 3 Study
Gastroenterology
◽
10.1016/s0016-5085(17)33661-2
◽
2017
◽
Vol 152
(5)
◽
pp. S1086
Author(s):
Maurizia Rossana Brunetto
◽
Young-Suk Lim
◽
Edward Gane
◽
Wai-Kay Seto
◽
Marina Osipenko
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
◽
Negative Chronic Hepatitis
Download Full-text
A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96
Journal of Hepatology
◽
10.1016/s0168-8278(17)30313-6
◽
2017
◽
Vol 66
(1)
◽
pp. S25-S26
◽
Cited By ~ 8
Author(s):
M. Brunetto
◽
Y.S. Lim
◽
E. Gane
◽
W.K. Seto
◽
M. Osipenko
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
◽
Negative Chronic Hepatitis
Download Full-text
A Phase 3 Study of Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF) in Patients With HBeAg-negative, Chronic Hepatitis B (CHB): Week 48 Efficacy and Safety Results
Clinical Gastroenterology and Hepatology
◽
10.1016/j.cgh.2016.09.108
◽
2017
◽
Vol 15
(1)
◽
pp. e44
Author(s):
Henry Lik-Yuen Chan
◽
Scott Fung
◽
Wai Kay Seto
◽
Wan-Long Chuang
◽
Chi-Yi Chen
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
◽
Negative Chronic Hepatitis
Download Full-text
IDDF2019-ABS-0169 A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results
10.1136/gutjnl-2019-iddfabstracts.278
◽
2019
◽
Author(s):
Henry Lik Yuen Chan
◽
Pietro Lampertico
◽
Maria Buti
◽
Scott Fung
◽
Sang Hoon Ahn
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
Download Full-text
Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Positive Patients: A Global Phase 3 Study
Gastroenterology
◽
10.1016/s0016-5085(17)33660-0
◽
2017
◽
Vol 152
(5)
◽
pp. S1085-S1086
Author(s):
Kosh Agarwal
◽
Scott Fung
◽
Wai-Kay Seto
◽
Young-Suk Lim
◽
Edward Gane
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
Download Full-text
FRI-183-A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results
Journal of Hepatology
◽
10.1016/s0618-8278(19)30928-4
◽
2019
◽
Vol 70
(1)
◽
pp. e470-e471
Author(s):
Pietro Lampertico
◽
Maria Buti
◽
Scott Fung
◽
Sang Hoon Ahn
◽
Wan-Long Chuang
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
Download Full-text
A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results
Journal of Hepatology
◽
10.1016/s0168-8278(20)30670-x
◽
2020
◽
Vol 73
◽
pp. S67-S68
Author(s):
Pietro Lampertico
◽
Maria Buti
◽
Alnoor Ramji
◽
Scott Fung
◽
Sang Hoon Ahn
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Tenofovir Alafenamide
Download Full-text
A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96
Journal of Hepatology
◽
10.1016/s0168-8278(17)31347-8
◽
2017
◽
Vol 66
(1)
◽
pp. S478
◽
Cited By ~ 16
Author(s):
K. Agarwal
◽
S. Fung
◽
W.K. Seto
◽
Y.S. Lim
◽
E. Gane
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Efficacy And Safety
◽
Phase 3
◽
Positive Chronic Hepatitis
◽
Tenofovir Alafenamide
Download Full-text
IDDF2018-ABS-0108 Improved bone and renal safety at 1 year after switching from TENOFOVIR DISOPROXIL FUMARATE (TDF) to TENOFOVIR ALAFENAMIDE (TAF): results from 2 phase 3 studies in HBEAG-positive and HBEAG-negative patients with chronic hepatitis B (CHB)
10.1136/gutjnl-2018-iddfabstracts.209
◽
2018
◽
Cited By ~ 1
Author(s):
Henry Lek-Yuen Chan
◽
Calvin Pan
◽
Maurizia Brunetto
◽
Aric Josun Hui
◽
Rajiv Mehta
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Phase 3
◽
Tenofovir Alafenamide
◽
Renal Safety
Download Full-text
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
The Lancet Gastroenterology & Hepatology
◽
10.1016/s2468-1253(19)30421-2
◽
2020
◽
Vol 5
(5)
◽
pp. 441-453
◽
Cited By ~ 9
Author(s):
Pietro Lampertico
◽
Maria Buti
◽
Scott Fung
◽
Sang Hoon Ahn
◽
Wan-Long Chuang
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis B
◽
Chronic Hepatitis B
◽
Tenofovir Disoproxil Fumarate
◽
Phase 3
◽
Double Blind
◽
Tenofovir Alafenamide
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close